Literature DB >> 15722956

Candidate psychiatric illness genes identified in patients with pericentric inversions of chromosome 18.

Ben S Pickard1, M Pat Malloy, Leanne Clark, Stéphanie Lehellard, Henrik L Ewald, Ole Mors, David J Porteous, Douglas H R Blackwood, Walter J Muir.   

Abstract

Both the long and short arms of chromosome 18 have been consistently identified as potential locations for schizophrenia and bipolar affective disorder susceptibility genes. We previously described the identification of two independent pericentric inversions of chromosome 18 [inv(18)(p11.31;q21.2) and inv(18)(p11.31;q21.1)] occurring in two small families in which carriers have been diagnosed with schizophrenia and bipolar affective disorder, respectively. Using fluorescence in situ hybridization on patient metaphase chromosomes we have identified the locations of all four chromosome breakpoints in the inversion carriers. Neither pericentric inversion results in a direct gene disruption. However, each inversion breakpoint has the potential to perturb local gene expression by position effect or by the separation of important regulatory (enhancer) sequences from the core gene sequences. Five genes in the localities of the breakpoints have been identified as good candidates for the genetic basis of psychiatric illness in these families; TTMA, a novel membrane spanning protein; TCF4, a basic helix-loop-helix transcription factor; DLGAP1, an interactor of the PSD-95 synaptic protein; and ARKL1 and ARKL2, novel members of the ubiquitin ligase gene family.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15722956     DOI: 10.1097/00041444-200503000-00007

Source DB:  PubMed          Journal:  Psychiatr Genet        ISSN: 0955-8829            Impact factor:   2.458


  12 in total

1.  [Surveillance in the group of schizophrenia: key to understanding the etiology].

Authors:  P Falkai; A Schmitt
Journal:  Nervenarzt       Date:  2013-09       Impact factor: 1.214

Review 2.  Transcription factor 4 (TCF4) and schizophrenia: integrating the animal and the human perspective.

Authors:  Boris B Quednow; Magdalena M Brzózka; Moritz J Rossner
Journal:  Cell Mol Life Sci       Date:  2014-01-12       Impact factor: 9.261

3.  Identification of ARKL1 as a Negative Regulator of Epstein-Barr Virus Reactivation.

Authors:  Umama Z Siddiqi; Anup S Vaidya; Xinliu Li; Edyta Marcon; Sai Wah Tsao; Jack Greenblatt; Lori Frappier
Journal:  J Virol       Date:  2019-09-30       Impact factor: 5.103

4.  Alternatively Spliced Genes as Biomarkers for Schizophrenia, Bipolar Disorder and Psychosis: A Blood-Based Spliceome-Profiling Exploratory Study.

Authors:  S J Glatt; S D Chandler; C A Bousman; G Chana; G R Lucero; E Tatro; T May; J B Lohr; W S Kremen; I P Everall; M T Tsuang
Journal:  Curr Pharmacogenomics Person Med       Date:  2009-09

5.  Identification of a novel protein interaction motif in the regulatory subunit of casein kinase 2.

Authors:  Jennifer Yinuo Cao; Kathy Shire; Cameron Landry; Gerald D Gish; Tony Pawson; Lori Frappier
Journal:  Mol Cell Biol       Date:  2013-11-11       Impact factor: 4.272

6.  PSTPIP2 deficiency in mice causes osteopenia and increased differentiation of multipotent myeloid precursors into osteoclasts.

Authors:  Violeta Chitu; Viorel Nacu; Julia F Charles; William M Henne; Harvey T McMahon; Sayan Nandi; Halley Ketchum; Renee Harris; Mary C Nakamura; E Richard Stanley
Journal:  Blood       Date:  2012-08-24       Impact factor: 22.113

7.  Differential DNA methylation in peripheral blood mononuclear cells in adolescents exposed to significant early but not later childhood adversity.

Authors:  Elisa A Esposito; Meaghan J Jones; Jenalee R Doom; Julia L MacIsaac; Megan R Gunnar; Michael S Kobor
Journal:  Dev Psychopathol       Date:  2016-02-05

8.  A screen for proteins that interact with PAX6: C-terminal mutations disrupt interaction with HOMER3, DNCL1 and TRIM11.

Authors:  Simon T Cooper; Isabel M Hanson
Journal:  BMC Genet       Date:  2005-08-12       Impact factor: 2.797

Review 9.  The DLGAP family: neuronal expression, function and role in brain disorders.

Authors:  Andreas H Rasmussen; Hanne B Rasmussen; Asli Silahtaroglu
Journal:  Mol Brain       Date:  2017-09-04       Impact factor: 4.041

10.  A Scaled Framework for CRISPR Editing of Human Pluripotent Stem Cells to Study Psychiatric Disease.

Authors:  Dane Z Hazelbaker; Amanda Beccard; Anne M Bara; Nicole Dabkowski; Angelica Messana; Patrizia Mazzucato; Daisy Lam; Danielle Manning; Kevin Eggan; Lindy E Barrett
Journal:  Stem Cell Reports       Date:  2017-10-10       Impact factor: 7.765

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.